Cited by 21Pharmaceutical Practices and Patient OutcomesPharmacy and Medical PracticesChronic Disease Management Strategies

The DOI matches its Crossref record.

A literature review: Polypharmacy protocol for primary care

Skinner, Mary·2015·Geriatric Nursing

Abstract

The purpose of this literature review is to critically evaluate published protocols on polypharmacy in adults ages 65 and older that are currently used in primary care settings that may potentially lead to fewer adverse drug events. A review of OVID, CINAHL, EBSCO, Cochrane Library, Medline, and PubMed databases was completed using the following key words: protocol, guideline, geriatrics, elderly, older adult, polypharmacy, and primary care. Inclusion criteria were: articles in medical, nursing, and pharmacology journals with an intervention, protocol, or guideline addressing polypharmacy that lead to fewer adverse drug events. Qualitative and quantitative studies were included. Exclusion criteria were: publications prior to the year 1992. A gap exists in the literature. No standardized protocol for addressing polypharmacy in the primary care setting was found. Mnemonics, algorithms, clinical practice guidelines, and clinical strategies for addressing polypharmacy in a variety of health care settings were found throughout the literature. Several screening instruments for use in primary care to assess potentially inappropriate prescription of medications in the elderly, such as the Beers Criteria and the STOPP screening tool, were identified. However, these screening instruments were not included in a standardized protocol to manage polypharmacy in primary care. Polypharmacy in the elderly is a critical problem that may result in adverse drug events such as falls, hospitalizations, and increased expenditures for both the patient and the health care system. No standardized protocols to address polypharmacy specific to the primary care setting were identified in this review of the literature. Given the growing population of elderly in this country and the high number of medications they consume, it is critical to focus on the utilization of a standardized protocol to address the potential harm of polypharmacy in the primary care setting and evaluate its effects on patient outcomes.

Overview

Integrity signals

Registry

Crossref · 10.1016/j.gerinurse.2015.05.003

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 25

  1. Bushardt, 2008, Polypharmacy: misleading but manageable, Clin Interv Aging, 3, 383, 10.2147/CIA.S2468 · DOI
  2. Viktil, 2008, The Janus face of polypharmacy-overuse versus underuse of medication, Norsk Epidemiol, 18, 147
  3. Francis, 2005, Switching of prescription drugs to over-the-counter status: Is it a good thing for the elderly?, Drugs Aging, 22, 361, 10.2165/00002512-200522050-00001 · DOI
  4. Zurakowski, 2009, The practicalities and pitfalls of polypharmacy, Nurse Pract, 34, 36, 10.1097/01.NPR.0000348320.38365.59 · DOI
  5. Ferrario, 2008, Geropharmacology: a primer for advanced practice acute care and critical care nurses, part 1, AACN Adv Crit Care, 19, 23
  6. Bregnhoj, 2009, Combined intervention program reduces inappropriate prescribing in elderly patients exposed to polypharmacy in primary care, Eur J Clin Pharmacol, 65, 199, 10.1007/s00228-008-0558-7 · DOI
  7. Maher, 2014, Clinical consequences of polypharmacy in the elderly, Expert Opin Drug Saf, 13, 57, 10.1517/14740338.2013.827660 · DOI
  8. Bilyeu, 2011, Reducing the use of potentially inappropriate medications in older adults, Am J Nurs, 111, 47, 10.1097/01.NAJ.0000393060.94063.15 · DOI
  9. Penge, 2013, Appropriate prescribing in older adults, Rev Clin Gerontol, 24, 56
  10. Lam, 2012, The use of STOPP/START criteria as a screening tool for assessing the appropriateness of medications in the elderly population, Expert Rev, 5, 187
  11. Ebell, 2004, Strength of Recommendation Taxonomy (SORT): a patient-centered approach to grading evidence in the medical literature, Am Fam Physician, 69, 548
  12. 2012, American Geriatric Society updated Beers criteria for potentially inappropriate medication use in older adults, J Am Geriatr Soc, 1
  13. Gallagher, 2008, STOPP (Screening Tool of Older persons' Potentially inappropriate Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment), Int J Clin Pharmacol Ther, 46, 72, 10.5414/CPP46072 · DOI
  14. Hanlon, 1992, A method for assessing drug therapy appropriateness, J Clin Epidemiol, 45, 1045, 10.1016/0895-4356(92)90144-C · DOI
  15. Gallagher, 2008, STOPP (Screening Tool of Older persons' Potentially inappropriate Prescriptions): application to acutely ill elderly patients and comparison with Beers' criteria, Age Ageing, 37, 673, 10.1093/ageing/afn197 · DOI · Paper page
  16. Hamilton, 2009, Inappropriate prescribing and adverse events in older people, BMC Geriatr, 10.1186/1471-2318-9-5 · DOI
  17. Bergman, 2013, Evidenced-based practice guideline: Improving medication management for older adult clients residing in long-term care facilities, J Gerontol Nurs, 39, 11, 10.3928/00989134-20130904-01 · DOI
  18. Zarowitz, 2005, Reduction of high-risk polypharmacy drug combinations in patients in a managed care setting, Pharmcotherapy, 25, 1636, 10.1592/phco.2005.25.11.1636 · DOI · Paper page
  19. Bushardt, 2005, Nine key questions to address polypharmacy in the elderly, J Am Acad Physician Assist, 18, 32, 10.1097/01720610-200505000-00005 · DOI
  20. Garfinkel, 2010, Feasibility study of a systematic approach for discontinuation of multiple medications in older adults, Arch Intern Med, 170, 1648, 10.1001/archinternmed.2010.355 · DOI
  21. Lee, 1998, Polypharmacy: a case report and new protocol for management, J Am Board Fam Pract, 11, 140, 10.3122/15572625-11-2-140 · DOI
  22. Haque, 2009, ARMOR: a tool to evaluate polypharmacy in elderly persons, Ann Longterm Care, 17, 26
  23. Shah, 2012, Polypharmacy, adverse drug reactions, and geriatric syndromes, Clin Geriatr Med, 28, 173, 10.1016/j.cger.2012.01.002 · DOI
  24. Hoskins, 2011, Safe prescribing for the elderly, Nurse Pract, 36, 47, 10.1097/01.NPR.0000407605.53599.a6 · DOI
  25. Wenger, 2007, ACOVE investigators, introduction to assessing the care of vulnerable elders–3 quality indicator measurement set, J Am Geriatr Soc, 55, S247

Cited by

Sorted by citations

Metadata

Authors
Skinner, M.
Affiliations
University of Louisville (US)
Corresponding author
Skinner, Mary
Venue
Geriatric Nursing
Publisher
Elsevier BV
Published
2015-09
Volume
36
Issue
5
Pages
367-371.e4
ISSN
0197-4572 (ISSN-L)
OpenAlex
W1851572632
Cited by
21
References
0
Citations by year
2026: 1 · 2024: 2 · 2023: 1 · 2022: 2 · 2021: 2 · 2020: 1 · 2019: 3 · 2018: 1 · 2017: 3 · 2016: 5
FWCI
1.52
Type
journal article
Language
en
Open access
closed
Locations
  • Geriatric Nursing (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
  • Health Sciences › Health Professions › Pharmacy › Pharmacy and Medical Practices
  • Health Sciences › Medicine › Epidemiology › Chronic Disease Management Strategies
Keywords
polypharmacy, older adults, primary care, adverse drug reactions, potentially inappropriate medications, screening tool, Beers criteria, STOPP, falls, hospitalization
MeSH terms
Aged, Aged, 80 and over, Geriatrics, Humans, Primary Health Care, Polypharmacy, Drug-Related Side Effects and Adverse Reactions

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review